SEC Form 4 · accession 0001209191-16-094975
Travere Therapeutics, Inc. · TVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jensen Margaret E Valeur
Officer — General Counsel
Period of report
Feb 1, 2016
Accepted (ET)
Feb 2, 2016 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2016 | A | 50,000 | $0.00 | A | 100,000 | D |
Table II — derivative securities
No Table II lines on this filing.